Disc Medicine, Inc. (IRON) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -62.24M | -43.3M | -47.8M | -47.92M | -41.38M | -27.57M | -17.36M | -15.39M | -33.6M | -17.8M | -7.48M | -12.72M | -35.47M | -12.4M | -9.69M | -9.19M | -13.7M | 19.5M | -16.1M | -15.93M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -50.42% | -57.04% | -175.32% | -211.3% | -23.15% | -54.94% | -132.22% | -20.98% | 5.26% | -43.46% | 22.86% | -38.39% | -158.86% | -163.62% | 39.79% | 42.28% | 8.7% | 320.24% | - | - |
| Net Income | -63.5M | -60.53M | -62.32M | -55.25M | -34.09M | -29.46M | -26.6M | -26.35M | -26.95M | -23.58M | -14.12M | -15.95M | -22.78M | -21.23M | -16.15M | -9.58M | -9.85M | -17.82M | -18.55M | -16.45M |
| Depreciation & Amortization | 89K | 89K | 87K | 85K | 20K | 9K | 11K | 110K | 26K | 25K | 25K | 25K | 25K | 300K | 24K | 22K | 18K | 46K | 58K | 62K |
| Stock-Based Compensation | 0 | 0 | 9.51M | 8.42M | 6.36M | 4.33M | 4.33M | 4.09M | 4.06M | 1.93M | 1.27M | 1.31M | 1.02M | 0 | 382K | 382K | 332K | 0 | 1.66M | 2.86M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 11.2M | 8.75M | -1.41M | -1.46M | -5.88M | 367K | -2.51M | -444K | 142K | -1.39M | -803K | 1.55M | 84K | -3.18M | 6.02M | -2.42M | -26K | 34.14M | 32K | 37K |
| Working Capital Changes | -10.02M | 8.39M | 6.33M | 283K | -7.79M | -2.83M | 7.4M | 7.2M | -10.88M | 5.22M | 6.15M | 339K | -13.82M | 11.7M | 30K | 2.4M | -4.17M | 3.14M | 705K | -2.44M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 2.74M | 1.75M | 918K | -321K | -1.28M | 4.39M | -1.05M | -669K | -7.36M | 3.97M | 3.77M | -726K | -10.75M | 2.34M | -403K | 1.99M | -982K | 1.77M | -501K | -2.13M |
| Cash from Investing | 58.31M | -222.89M | 49.54M | 51.69M | -272.63M | -1.43M | -71.09M | -219.75M | -67K | -3K | -45K | -12K | -29K | -151K | -19K | -20K | -100K | -7K | -61K | -1.5K |
| Capital Expenditures | 0 | -20K | -26K | -36K | -851K | -449K | 8K | 3K | -67K | -3K | -45K | -12K | -29K | -151K | -19K | -20K | -100K | -7K | -61K | -1.5K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 1.7M | 216.68M | 11.59M | 892K | 244.25M | 28.8M | 426K | 173.19M | 15.9M | 7.76M | 460K | 153.85M | 77.31M | 154.34M | 22K | 86K | 55K | -102.73M | -1.25M | -1.58M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 27.59M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.42M | -2.92M | -1.25M | -1.25M | 3.33M | -1.25M | -1.25M |
| Equity Issued (Net) | 1.01M | 216.1M | 11.59M | 892K | 234M | 761K | -171K | 172.62M | 14.85M | 6.95M | -100K | 143.4M | 48.82M | 53.67M | 0 | 0 | 0 | 89.82M | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 687K | 578K | 0 | 0 | 10.25M | 441K | 597K | 567K | 1.05M | 806K | 560K | 10.45M | 28.48M | 95.26M | 2.94M | 1.34M | 1.3M | -195.88M | 0 | -331K |
| Net Change in Cash | 7.75M | -59.5M | 13.33M | 4.66M | -69.76M | -202K | -88.03M | -61.95M | -17.77M | -10.04M | -7.06M | 141.12M | 41.81M | 93.05M | -9.69M | -9.13M | -13.75M | -61.86M | -17.41M | -17.51M |
| Free Cash Flow | -62.24M | -43.32M | -47.83M | -47.95M | -42.23M | -28.02M | -17.35M | -15.39M | -33.67M | -17.8M | -7.52M | -12.74M | -35.49M | -12.56M | -9.71M | -9.21M | -13.8M | 19.49M | -16.16M | -15.93M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -47.38% | -54.59% | -175.6% | -211.59% | -25.43% | -57.44% | -130.73% | -20.84% | 5.15% | -41.76% | 22.55% | -38.22% | -157.19% | -164.42% | 39.9% | 42.15% | 8.04% | 320.16% | - | - |
| FCF per Share | -1.62 | -1.23 | -1.36 | -1.37 | -1.27 | -0.94 | -0.58 | -0.60 | -1.36 | -0.76 | -0.31 | -0.59 | -1.87 | -12.56 | -10.11 | -9.75 | -14.94 | 7.63 | -3.75 | -3.70 |
| FCF Conversion (FCF/Net Income) | 0.98x | 0.72x | 0.77x | 0.87x | 1.21x | 0.94x | 0.65x | 0.58x | 1.25x | 0.75x | 0.53x | 0.80x | 1.56x | 0.58x | 0.60x | 0.96x | 1.39x | -1.09x | 0.87x | 0.97x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 198K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35K | 36K | 47K | 0 | 0 | 84K |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 262K | 4K | 33K | 0 | 34K | 78K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |